A Trial Investigating the Pharmacodynamic Properties of NN5401 in Young Adults and Geriatric Subjects With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Insulin degludec/insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Novo Nordisk
- 22 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 09 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.